Table 2 Clinical characteristics
From: Hypothermia does not increase the risk of infection: a case control study
| Â | Normothermia (n= 35) | Hypothermia (n= 35) | P value |
|---|---|---|---|
Length of stay in ICU (days) | 11 (7.0 to 18.0) | 10.0 (6.0 to 14.0) | 0.830 |
Length of mechanical ventilation (days) | 10 (7.0 to 17.0) | 9.0 (6.0 to 14.0) | 0.969 |
ICU mortalitity n (%) | 17 (48.6%) | 29 (82.9%) | 0.004 |
Hemodynamic instability n (%) | 6 (17.1%) | 6 (17.1%) | 1.000 |
Use of catecholamines n (%) | 32 (91.4%) | 34 (97.1%) | 0.625 |
Maximum amount of norepinephrine ug/kg/min | 0.18 (0.13 to 0.26) | 0.35 (0.16 to 0.55) | 0.053 |
Maximum amount of dobutamine ug/kg/min | 5.28 (3.33 to 7.19) | 3.70 (2.28 to 4.60) | 0.086 |
Patients receiving sedation n (%) | 35 (100%) | 35 (100%) | NA |
Maximum amount of propofol mg/kg/hr | 3.5 ± 1.5 | 3.7 ± 1.2 | 0.737 |
Maximum amount of midazolam mg/kg/hr | 0.25 ± 0.11 | 0.31 ± 0.10 | 0.043 |
Maximum amount of insulin IU/hr | 5.0 (3.0 to 7.0) | 5.0 (3.0 to 7.0) | 0.378 |
Patients receiving PN n (%) | 13 (37.1%) | 24 (68.6%) | 0.013 |
Leucocytes minimum count 10^9/l | 7.8 (5.1 to 9.3) | 5.8 (4.9 to 8.2) | 0.191 |
Leucocytes maximum count 10^9/l | 19.4 ± 6.6 | 20.7 ± 6.4 | 0.386 |